PublizoomCall for tenders Supplies
Raamovereenkomst voor de levering van Aflibercept
Notice published in Dutch. The AI analysis summarises it for you in your language.
Tenders due closed — 31 July 2026 at 09:00
- Public buyer
- AZ Sint-Lucas vzw
Brugge - Place of performance
- 8310 Brugge, West Flanders
- Planned end of contract
- 30 September 2030
- Form
- Framework agreement
Multi-year contract: the buyer places orders as needs arise. - Procedure
- Open procedure
Any company may submit a bid. - Publication
- 2 July 2026
- Notice language
- Dutch
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Voorwerp van deze leveringen: Perceel 1: Aflibercept (40mg/1ml) - Voorgevulde spuit geregistreerd voor volgende indicaties:
- neovasculaire (natte) leeftijdsgebonden maculadegeneratie (LMD)
- visusverslechtering als gevolg van macula-oedeem secundair aan retinale veneuze occlusie
- visusverslechtering als gevolg van diabetisch macula-oedeem (DME)
- visusverslechtering als gevolg van myope choroïdale neovascularisatie (myope CNV) Perceel 2: Aflibercept (40mg/1ml) - Voorgevulde spuit geregistreerd voor de volgende indicatie: 1. de behandeling van een oogaandoening met de naam prematuren-retinopathie (ROP) Perceel 3: Aflibercept (40mg/1ml) - Flacon Het betreft een raamovereenkomst voor 2 jaar, en is 2 maal verlengbaar met een periode van 1 jaar.
De verlenging gebeurt stilzwijgend, bij niet verlenging wordt dit minimum 90 kalenderdagen voor de vervaldatum van de opdracht door de aanbestedende overheid doorgegeven.
3 lots
- Aflibercept (40mg/1ml) - Voorgevulde spuit
- Aflibercept (40mg/1ml) - Voorgevulde spuit
- Aflibercept (40mg/1ml) - Flacon
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33690000
Winning prices for comparable contracts
- A quarter below
- €444,216
- Median
- €606,904
- A quarter above
- €1,514,536
Amounts awarded (excl. VAT) over the last 3 years for 27 contracts in the same CPV group (3369…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Likely competitors: who wins with this buyer in this field
- HEMOTECH BELUX · 1 contract won
- Celltrion Healthcare Netherlands B.V. · 1 contract won
- MEDLINE INTERNATIONAL BELGIUM BVBA · 1 contract won
- CANON MEDICAL SYSTEMS BELGIUM NV/SA · 1 contract won
- DUOMED BELGIUM · 1 contract won
Partners and subcontractors
Contract too big or too broad for you alone? Bid as a temporary consortium, or offer your services as a subcontractor.
Create your free account to see who is looking for a partner on this contract, and to register.
Companies winning this type of contract in the region
- Fresenius Kabi NV · 3 contracts won in 3 years
- Celltrion Healthcare Netherlands B.V. · 2 contracts won in 3 years
- EG NV · 2 contracts won in 3 years
- SANDOZ · 2 contracts won in 3 years
- HEMOTECH BELUX · 1 contract won in 3 years
- CSL BEHRING · 1 contract won in 3 years
- Ipsen · 1 contract won in 3 years
- Pharmanovia Benelux B.V. · 1 contract won in 3 years
Possible partners for a temporary consortium or subcontracting… and competitors worth knowing.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Raamovereenkomst voor afname van dialyseconcentraten AZ Sint-Lucas vzw · 21 October 2026 |
HEMOTECH BELUX | €1,128,000 |
| Raamovereenkomst voor de levering van Tocilizumab AZ Sint-Lucas vzw · 7 October 2026 |
Celltrion Healthcare Netherlands B.V. | €1,229,160 |
| SUPPLEMENTS NUTRITIONNELS ORAUX (SNO) - hypercaloriques et hyperprotéinés, avec fibres Centre Hospitalier Régional de Huy · 23 October 2026 |
Fresenius Kabi | €259,714 |
| Luspatercept VITAZ vzw · 22 October 2026 |
Orifarm Belgium | €3,000,000 |
| Acquisition de produits reactifs pour les sequenceurs illumina Université Libre de Bruxelles · 20 October 2026 |
ILLUMINA BELGIUM | €410,000 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 455937-2026.